Company news

Zhejiang Chengyi Pharmaceutical Co. Ltd. news in 2025

Zhejiang Chengyi Pharmaceutical Co. Ltd.'s news releases, calls and decks from 2025, newest first.

View company

Announcement on the Acquisition of Drug Registration Certificate for Torasemide Tablets

December 9, 2025

Announcement on Progress in Providing Guarantee

December 2, 2025

Announcement on Completing Shareholding Reduction Plan for Person Acting in Concert of Controlling Shareholder and the Results of Shareholding Reduction

November 26, 2025

Indicative Announcement on Change in Equity of Controlling Shareholders and Persons Acting in Concert Reaching 1% Scale

November 14, 2025

Report for Q3 2025

October 27, 2025

Announcement on Completion of the Government’s Compensatory Recovery of Land and Associated Assets of Subsidiaries

October 13, 2025

Announcement on Shareholding Reduction Plan for Person Acting in Concert of Controlling Shareholder

September 19, 2025

Announcement on Outline of the 2025 Semi-annual Performance Briefing

September 18, 2025

Announcement on Completion of Non-trading Transfer under the 2025 Employee Stock Ownership Plan

September 17, 2025

Announcement on Resolutions of the 1st Holders' Meeting for 2025 Employee Stock Ownership Plan

September 16, 2025

Announcement on Resolutions of the 2nd Extraordinary General Meeting in 2025

September 15, 2025

Announcement on the Company's Drug Passing Consistency Evaluation of Generic Drug

September 12, 2025

Announcement on Obtainment of Drug Registration Certificate for Icosapent Ethyl Soft Capsules

September 1, 2025

Announcement on Appointment of Deputy General Manager

August 26, 2025

Announcement on Retirement and Resignation of Senior Management Member

August 18, 2025

Announcement on Resolutions of the 1st Extraordinary General Meeting in 2025

August 11, 2025

Announcement on Abnormal Fluctuations in Stock Trading

August 6, 2025

Announcement on Progress in Repurchasing Shares through Call Auction

August 4, 2025

Announcement on the Acquisition of Drug Registration Certificate for Peramivir Injection

July 31, 2025

Semi-annual Earnings Preannouncement for 2025

July 13, 2025

Announcement on Implementation of Dividend Distribution for 2024

June 11, 2025

Announcement on Convening the 2024 Annual and Q1 2025 Performance Briefing

June 4, 2025

Announcement on Election of Employee Director for the 5th Board of Directors

May 20, 2025

Report for Q1 2025

April 29, 2025

Announcement on the Acquisition of Drug Registration Certificate for Mercaptopurine Tablets

April 14, 2025

Announcement on Obtaining Australia's TGA-GMP Certificate

January 10, 2025

Announcement on the Acquisition of Drug Registration Certificate for Calcitriol Soft Capsules

January 2, 2025